Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Alto Neuroscience, Inc. (ANRO) had Operating Cash Flow per Share of $-0.61 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-15.17M |
|
-- |
|
-- |
|
$15.68M |
|
$-15.68M |
|
$0.51M |
|
$-15.17M |
|
$-15.17M |
|
$-15.17M |
|
$-15.17M |
|
$-15.17M |
|
$-15.17M |
|
$-15.68M |
|
$-15.51M |
|
27.05M |
|
27.05M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$163.52M |
|
$2.48M |
|
$8.39M |
|
$171.91M |
|
$7.26M |
|
$21.15M |
|
$25.56M |
|
$32.82M |
|
$139.10M |
|
$139.10M |
|
$139.10M |
|
27.07M |
|
| Cash Flow Statement Financials | |
$-16.56M |
|
$-0.02M |
|
$9.13M |
|
$168.73M |
|
$161.25M |
|
$-7.47M |
|
$1.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.53 |
|
-- |
|
-- |
|
0.13 |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.91% |
|
-10.91% |
|
-8.82% |
|
-9.47% |
|
$5.14 |
|
$-0.61 |
|
|
Operating Cash Flow per Share |
$-0.61 |